The Horizon Technology (HT) approach identifies new and emerging health-promoting technologies as well as persistent problems and trends likely to have a significant impact on health and health care systems around the world, scanning and monitoring various health information sources to identify promising technologies not yet widely utilized, and generally exploring factors at the margins of current thinking that challenge past assumptions.
Publications sought for this Research Topic will summarize information regarding -but not limited to- (bio)technologies, available evidence, regulatory status and potential costs, and promising new bioactive molecules or new drug delivery systems, with concomitant development and implementation issues. Health technologies to be tackled will also include devices, procedures, diagnostics, and other health interventions.
Studies of the effects and potential of these biomedical innovations should be enriched by considerations such as trend impact analysis (or cross impact analysis), clinical evidence of efficacy, cost-effectiveness; comparative effectiveness, therapeutic risk management; drug utilization research; causal layered analysis; environmental scanning; growth and envelope curves (judgment); Monitoring Morphological Analysis; Network Analysis (market); Technology Forecasting etc.
This Research Topic seeks to play a part in catalysing solutions to some of the current challenges for the application of pharmaceutical/ health technology innovation - specifically the use of rational, evidence-based approaches. Inappropriate use and over-use of technologies, particularly medical waste of resources – often with out-of-pocket payments by patients – result in significant patient harm in terms of poor patient outcomes and adverse drug reactions.
We propose the investigation of a variety of paradigm-shifting factors such as innovative combinations of traditional utilization studies with qualitative approaches (e.g. focus group discussion, in-depth interviews, structured observation and structured questionnaires), development and acceptance of innovative ideas, the impact of contemporary discoveries, and theoretical advances and technological developments. Review papers and original research articles will be welcome in addition to papers that provide a link between basic research and clinical practice. A particular emphasis will be given to the technological development of new health care/services approaches.
The Horizon Technology (HT) approach identifies new and emerging health-promoting technologies as well as persistent problems and trends likely to have a significant impact on health and health care systems around the world, scanning and monitoring various health information sources to identify promising technologies not yet widely utilized, and generally exploring factors at the margins of current thinking that challenge past assumptions.
Publications sought for this Research Topic will summarize information regarding -but not limited to- (bio)technologies, available evidence, regulatory status and potential costs, and promising new bioactive molecules or new drug delivery systems, with concomitant development and implementation issues. Health technologies to be tackled will also include devices, procedures, diagnostics, and other health interventions.
Studies of the effects and potential of these biomedical innovations should be enriched by considerations such as trend impact analysis (or cross impact analysis), clinical evidence of efficacy, cost-effectiveness; comparative effectiveness, therapeutic risk management; drug utilization research; causal layered analysis; environmental scanning; growth and envelope curves (judgment); Monitoring Morphological Analysis; Network Analysis (market); Technology Forecasting etc.
This Research Topic seeks to play a part in catalysing solutions to some of the current challenges for the application of pharmaceutical/ health technology innovation - specifically the use of rational, evidence-based approaches. Inappropriate use and over-use of technologies, particularly medical waste of resources – often with out-of-pocket payments by patients – result in significant patient harm in terms of poor patient outcomes and adverse drug reactions.
We propose the investigation of a variety of paradigm-shifting factors such as innovative combinations of traditional utilization studies with qualitative approaches (e.g. focus group discussion, in-depth interviews, structured observation and structured questionnaires), development and acceptance of innovative ideas, the impact of contemporary discoveries, and theoretical advances and technological developments. Review papers and original research articles will be welcome in addition to papers that provide a link between basic research and clinical practice. A particular emphasis will be given to the technological development of new health care/services approaches.
